| Radioisotopes |
|
The portfolio of ITG radioisotopes and generators utilized in the ITM Group has been carefully selected and developed to comply with a set of narrow and challenging specifications. The ITM radioisotope production and supply systems are optimized to meet the quality and supply standards (interuption free, security of supply) required in a dynamically developing environment of a new generation of targeted, personalized therapies. All radioisotope related production and logistics services are provided by ITG Isotope Technologies Garching GmbH ("ITG") a wholly owned subsidiary of ITM AG: ITG has development projects on variety of radioisotopes Lu-177 n.c.a., Re-188 and Ac-225/Bi-213.
|
||
News
ITG has received the Manufacturing License for Lu-177 n.c.a.As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |
